Arbutus Biopharma Corp (ABUS) financials · rev $14.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Arbutus Biopharma Corp (ABUS) rev $14.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $14.1M | $6.17M |
| Operating Income | -$38.2M | -$76.3M |
| Net Income | -$33.5M | -$69.9M |
| EPS (Diluted) | -$0.17 | -$0.38 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $94.6M | $131.7M |
| Current Assets | $94.5M | $127.3M |
| Cash & Equivalents | $18.0M | $36.3M |
| PP&E | $32.0K | $3.31M |
| Total Liabilities | $18.0M | $34.3M |
| Current Liabilities | $6.01M | $15.6M |
| Long-term Debt | N/A | N/A |
| Shareholders' Equity | $76.6M | $97.4M |
| Retained Earnings | -$1.38B | -$1.35B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$39.6M | -$64.8M |
| CapEx | N/A | $182.0K |
| Investing Cash Flow | $15.6M | $22.9M |
| Financing Cash Flow | $5.72M | $52.0M |
| Net Change in Cash | -$18.3M | $10.0M |
| Free Cash Flow | -$39.6M | -$65.0M |
FAQ
What is ABUS P/E and revenue?
Arbutus Biopharma Corp (ABUS) rev $14.1M.
What is ABUS revenue?
Arbutus Biopharma Corp last cached revenue is $14.1M (FY2025).
Is ABUS profitable?
Arbutus Biopharma Corp last cached net income is -$33.5M (FY2025).
What are ABUS total assets?
Arbutus Biopharma Corp last cached total assets are $94.6M (FY2025).
What is ABUS free cash flow?
Arbutus Biopharma Corp last cached free cash flow is -$39.6M (FY2025).
Not investment advice. Cached statements, not a live tape.